Dr Clíona Farrell was a Volunteer Writer at BioNews, having originally joined the publication under the auspices of its writing scheme. She completed a PhD in the Wiseman Lab of the UK Dementia Research Institute at University College London. Clíona's research was focused on understanding the genetic and cellular mechanisms of neuroinflammation in Alzheimer's disease in Down syndrome. She previously worked as a research assistant in the Royal College of Surgeons in Ireland after completing her undergraduate degree in Neuroscience in Trinity College Dublin.
Delivering an enzyme-replacement therapy to a fetus via its umbilical cord prevented a child from developing symptoms of a rare genetic condition, in a first-of-its-kind clinical trial...
A new genetic predictor method can identify people at risk of developing Alzheimer's disease, years before symptom onset...
Crucial role of sperm DNA-packaging protein has been identified in mice, which causes infertility when truncated...
Uterus transplants in the USA have been shown to be safe for recipients and donors, with a high percentage of successful pregnancies resulting from them...
Teenagers born through fertility treatment have a one percent higher prevalence of mental health disorders, but no difference in school performance, new study shows...
The BBC's CrowdScience podcast calls on listeners to ask the scientific questions they've always wanted answered, from medicine, to the Earth and beyond. In the latest episode of the series, host Caroline Steel delves into the world of genome editing, from success stories in the clinic, to the pragmatic ethical concerns...
NHS-funded IVF cycles were slower to resume on average than privately-funded treatments after the mandatory closure of all UK clinics due to the COVID-19 pandemic...
A mitochondrial gene has been identified as a potential therapeutic target for prostate cancers that have spread to other parts of the body and evade current treatment strategies...
A widower is seeking High Court approval to use a single remaining embryo he created with his deceased wife, for which he has no written consent...
Whole genome sequencing is being used to offer brain tumour patients personalised treatment in a first-of-its-kind NHS trial...
Subscribe for free to what PET does best – informing you of the latest in fertility, genomics and embryo research.
